![]() |
市場調査レポート
商品コード
1619215
腎臓・泌尿器デバイスの市場規模・シェア・成長分析 (製品別、用途別、地域別):産業予測 (2024~2031年)Nephrology and Urology Devices Market Size, Share, Growth Analysis, By Product (Ureteral Catheters, PCN Catheters), By Application (Urolithiasis, Urological Cancer & BPH), By Region - Industry Forecast 2024-2031 |
||||||
|
腎臓・泌尿器デバイスの市場規模・シェア・成長分析 (製品別、用途別、地域別):産業予測 (2024~2031年) |
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
|
世界の腎臓・泌尿器デバイス市場規模は2022年に56億米ドルと評価され、2023年の59億8,000万米ドルから2031年には101億2,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは6.8%で成長する見通しである
世界の腎臓・泌尿器デバイス市場には、透析装置、カテーテル、ロボット手術システムなど、腎臓・泌尿器系疾患の診断・治療用医療機器が幅広く含まれています。市場の成長を促進する要因としては、腎臓病の罹患率の上昇、医療技術の進歩、人口の高齢化などが挙げられます。慢性腎臓病は世界の健康上の重要課題として浮上しており、その結果、さまざまな腎臓内科機器や腎治療に対する需要が増加しています。同市場は、多国籍企業や地域企業との間の激しい競合が特徴であり、各社は製品ラインナップを充実させるために研究開発に多額の投資を行っています。低侵襲手技への動向が続く中、腎臓・泌尿器デバイス市場は持続的成長の態勢を整えており、医療イノベーションと患者ケアの利害関係者に十分な機会を提供しています。
The Nephrology and Urology Devices Market size was valued at USD 5.60 billion in 2022 and is poised to grow from USD 5.98 billion in 2023 to USD 10.12 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031)
The global nephrology and urology devices market encompasses a broad spectrum of medical equipment for diagnosing and treating kidney and urinary system disorders, including dialysis machines, catheters, and robotic surgical systems. Factors driving market growth include the rising incidence of kidney diseases, advancements in medical technology, and an aging population. Chronic kidney disease has emerged as a key global health challenge, resulting in increased demand for various nephrology devices and renal therapies. The market is characterized by intense competition among multinational corporations and regional players who are investing significantly in research and development to enhance product offerings. As the trend towards minimally invasive procedures continues, the nephrology and urology devices market is poised for sustained growth, offering ample opportunities for stakeholders in healthcare innovation and patient care.
Top-down and bottom-up approaches were used to estimate and validate the size of the The Nephrology and Urology Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The Nephrology and Urology Devices Market Segmental Analysis
Global Nephrology and Urology Devices Market is segmented by Product, by Application, by End User and by Region. Based on Product, the market is segmented into Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, Others. Based on Application, the market is segmented into Urolithiasis, Urological Cancer & BPH, Bladder Disorders, Kidney Diseases, Others. Based on End User, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Driver of the The Nephrology and Urology Devices Market
The Nephrology and Urology Devices market is significantly driven by the growing investments in healthcare infrastructure, alongside the rising prevalence of related illnesses. Enhanced healthcare spending facilitates the modernization of facilities and equipment, creating a favorable environment for the development of nephrology and urology devices. Moreover, various government initiatives aimed at bolstering healthcare systems through increased funding further contribute to the market's growth. This combination of higher healthcare expenditures and the escalating rates of nephrology and urological disorders not only highlights the urgent need for advanced medical technologies but also positions this market for robust expansion in the coming years.
Restraints in the The Nephrology and Urology Devices Market
The Nephrology and Urology Devices market encounters significant restraints, including a shortage of skilled labor, which hinders its growth. Additionally, while advancements in safety, effectiveness, and reduced side effects promote faster recovery in patients, these factors can paradoxically impede extensive market expansion. Furthermore, the inadequacies in healthcare infrastructure, particularly in developing countries, pose substantial challenges. The limited availability of trained professionals with the necessary expertise to operate these advanced devices compounds the issue, ultimately impacting the overall progress and potential of the nephrology and urology devices market in those regions.
Market Trends of the The Nephrology and Urology Devices Market
The nephrology and urology devices market is currently experiencing significant trends driven by patient-centric care and technological innovation. A notable trend is the increasing adoption of minimally invasive procedures, favored for their ability to enhance recovery times and diminish complications. This shift has spurred the development of advanced tools, including robotic surgical systems and laser lithotripsy technologies. Additionally, the integration of digital solutions such as artificial intelligence, telemedicine, and machine learning is transforming practice paradigms, promoting personalized medicine and facilitating home-based care. Together, these trends underscore the industry's commitment to improving patient outcomes while prioritizing sustainable practices in device manufacturing, marking a pivotal evolution in the field.